Joseph A. Markenson, MD

Appointments

Attending Physician, Hospital for Special Surgery

Professor of Clinical Medicine, Weill Medical College of Cornell University

Specialty

Rheumatology

Special Expertise

Rheumatoid arthritis

Osteoarthritis

Systemic lupus erythematosus

Awards

Lupus Erythematosus Foundation Fellow, 1975-76

Diplomate, American Board of Internal Medicine, 1976

Diplomate, American Board of Internal Medicine, 1978

Affiliations

Subspecialty Board of Rheumatology, Member

Education

MD, 1970, State University of New York-Downstate Medical Center, New York, US

Residency

The New York Hospital, Weill Medical College of Cornell University - Internal Medicine, US

Certification

Internal Medicine

Rheumatology

State Licensure

New York  

Joseph A. Markenson, MD is the author of the following articles on HSS.edu:

Selected Publications

  

For more publications, please see the PubMed listing.  

Research Description

Dr. Markenson is the principal investigator for drug studies involving patients with Rheumatic Diseases (Rheumatoid Arthritis, Osteoarthritis and Lupus). Ongoing recruitment for enrollment in studies currently active. Patients interested in more information or to participate in a Clinical Drug Trial should call his office at 212.606.1261.

Clinical Trials

• CORRONA Data Collection Program
• (Roche WA 180063) A Randomized, double-blind, placebo-controlled, parallel group study of the safety and reduction of signs and symptoms during treatment with Myeloma Receptor Antagonist (MRA)
• (Roche WA 180062) A Randomized, double-blind, placebo-controlled, parallel group study of the safety and reduction of signs and symptoms during treatment with Myeloma Receptor Antagonist (MRA)
• A Double-Blind, Randomized Trial of Intra-Articular injections of 20 mg of Hyalgan® for the Treatment of Knee Pain Due to Osteoarthritis (Three-injection regimen Efficacy and Duration-20 mg/2ml Dose: Tread-20): Sanofi Protocol #L-9385